Factors Associated With Success of NIPPV in ALS Patients
NCT ID: NCT05581771
Last Updated: 2024-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
51 participants
OBSERVATIONAL
2022-10-18
2023-10-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Initiation of Noninvasive Ventilation in ALS Patients With Chronic Respiratory Insufficiency
NCT06286917
Effects of Nocturnal Non-invasive Ventilation in Patients With Amyotrophic Lateral Sclerosis
NCT00958048
Efficacy of Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS)
NCT00537641
Optimizing INITIation of Non-invasive Ventilation in ALS Patients
NCT05033951
Amyotrophic Lateral Sclerosis Non-invasive Ventilation Exchange
NCT05837507
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged ≥ 19 years
* Patients who performed blood gas analysis including venous blood gas and arterial blood gas before NIPPV application.
Exclusion Criteria
* Patients who applied in outpatient settings
* Patients who did not perform blood gas analysis before NIPPV application
* Patietns who had a history of asthma or COPD,
* Patients who didn't have any record of NIPPV application time
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Bundang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jaewon Beom
Clinical Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jaewon Beom, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Rehabilitation Medicine, Seoul National University Bundang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Bundang Hospital
Seongnam-si, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B-2210-786-107
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.